BGIM
TBPH icon

Brandywine Global Investment Management’s Theravance Biopharma TBPH Stock Holding History

Brandywine Global Investment Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-93,249
Closed -$946K – 779
2022
Q3 		$946K Sell
93,249
-3,551
-4% -$33.3K 0.01% 625
2022
Q2 		$877K Sell
96,800
-14,300
-13% -$132K 0.01% 619
2022
Q1 		$1.06M Hold
111,100
– – 0.01% 618
2021
Q4 		$1.23M Buy
+111,100
New +$968K 0.01% 572

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Brandywine Global Investment Management's TBPH Position: Q4 2022 in Review

Brandywine Global Investment Management sold out of Theravance Biopharma (TBPH) in Q4 2022, closing a stake of 93,249 shares — an estimated $946K sold.

Brandywine Global Investment Management first reported a position in TBPH in Q4 2021 and held it in 4 quarters. The position peaked at $1.23M in Q4 2021. 119 funds tracked by Wall St. Rank hold TBPH as of Q4 2022.

  • Brandywine Global Investment Management reported no remaining Theravance Biopharma position as of Q4 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 93,249 Theravance Biopharma shares in Q4 2022, an estimated $946K.
  • Brandywine Global Investment Management first reported a position in Theravance Biopharma in Q4 2021 and held it in 4 quarters.
  • Brandywine Global Investment Management's Theravance Biopharma position peaked at $1.23M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2022.

Based on Brandywine Global Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.